Препарат лентивируса и трансдукция лентивируса для клеток протоковой аденокарциномы поджелудочной железы
Please note that all translations are AI generated. Click here for the English version.
65 Views
•
02:57 min
•
February 2nd, 2024
DOI :
February 2nd, 2024
•Amani Alshaikh1,2, Dmytro Grygoryev3, Dove Keith4, Brett Sheppard4,5, Rosalie C Sears4,6, Jungsun Kim3,6, Abdenour Soufi1
1Centre for Regenerative Medicine, Institute of Regeneration and Repair, Institute of Stem Cell Research, The University of Edinburgh, 2King Abdulaziz City for Science and Technology Health Sector (KACST), 3Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, 4Brenden-Colson Canter for Pancreatic Care, Oregon Health & Science University, 5Department of Surgery, Oregon Health & Science University, 6Department of Molecular & Medical Genetics, Oregon Health & Science University
Transcript
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved